Pharmaceuticals Market Research Reports

Pharmaceutical Market

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this industry. The pharmaceutical market, valued as a multi-billion dollar market, is undoubtedly the largest revenue generator for the life sciences industry.

The pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications. The largest segment, the market for cardiovascular drugs, records huge sales every year. The rising world population, rapid ageing of the same, and an increased prevalence of diseases are the major factors driving growth of this industry. The recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry, for the possibility of newer, advanced, and more sophisticated therapies and drugs. Developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals, regenerative medicine, stem cells, etc. These new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders. Technological growth in such interdisciplinary fields has opened up new arenas in drug discovery, drug delivery, and life sciences research.
Certain incurable diseases like cancer and AIDS, which are therapeutic areas of prime concern for scientists and doctors all over the world, depict immense growth potential for the pharmaceutical industry in the future. Surfacing of newer diseases and therefore, the rising requirement of newer drug delivery methods, explains the greater than before importance of research and development activities in the industry. Industry leaders now generously allocate around 20% of their turnover to R&D to allot the finest instruments and manpower for their use. This has helped them maintain a competitive edge over other players in the market. However, the high costs of R&D, shorter product life cycles, and trouble producing a ‘best-seller’ has introduced the trend of mergers, acquisitions, strategic alliances, and most importantly, outsourcing in the industry. Numerous companies have been entering into global tie-ups and collaborations pooling and utilizing their resources for R&D and new product development in almost all areas. With this ongoing and rapidly developing trend, countries have shown great interest in encouraging investments in developing R&D and manufacturing facilities by public funding and tax exemptions.

The industry, however, faces certain major challenges, one of them being the imbalance between the rate of introduction of novel drugs and that of patent expiry of the already existing brands. Rising research investments, development of better infrastructure, efficient allocation of resources, etc. are some of the measures adopted by players to cope with this problem. Stringent governmental regulation of this market in certain countries also sometimes restricts growth and causes loss of potential opportunities. However, certain regulatory measures such as patent protection for novel and blockbuster drugs helps manufacturers recover the massive investment costs incurred during the discovery, development, and commercialization of products. On the other hand, there are generic versions of drugs which are available at minimal prices as compared to patented drugs. These address the issue of affordability of drugs to the lower income groups.
Presently, the global pharmaceutical market is dominated by the United States. But huge double-digit growth rates are being observed in developing countries too, China and India being the best examples. This is mainly due to a large number of established multinational pharmaceutical companies outsourcing their research and manufacturing activities to these countries, owing to the favorable cost factor, modernized infrastructure, and a large and skilled base of scientifically knowledgeable manpower. Also, other emerging regional markets like Brazil, Russia, Germany, France, Spain, etc., continue to show tremendous growth in the pharmaceutical sector.

This section on pharmaceutical industry research consists of market research reports on its various segments like Cardiovascular drugs, Anesthesia drugs, Drug Discovery and Development, Dentistry, Dermatology, Blood and blood products, Clinical Diagnostics,  In vitro/Molecular Diagnostics, Radiology, Oncology, Dietary Supplements, Vaccines, Generics, and OTC drugs. The reports presented in this section include in-depth industry analysis involving major market players, latest market trends, new product developments, growth drivers, growth restrainers, market forecasts, and so on.

view less
RSS Sort By :
TITLE Price Buy Now More options

The Omega-3 PUFA market is poised to exhibit a strong growth in the next five years. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are rapidly growing types of Omega-3 PUFA and also garner the largest market share. The market for DHA ...

$ 4650


The global specific immunotherapy (SIT) market for allergic rhinitis (AR) is highly fragmented, with the US, Europe, and Japan having different SIT formulations available, under different regulatory restrictions, with almost no historical company ...

$ 7995


This is a professional and depth research report on Global Diabetes Drugs industry. The report firstly introduced Diabetes Drugs basic information included Diabetes Drugs definition classification application industry chain structure industry over...

$ 3600


Global Markets Direct's, ‘Secondary Hyperparathyroidism Pipeline Review, H2 2014', provides an overview of the Secondary Hyperparathyroidism's therapeutic pipeline.This report provides comprehensive information on the therapeuti...

$ 2000


Global Markets Direct's, ‘Vitiligo Pipeline Review, H2 2014', provides an overview of the Vitiligo's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Vitiligo, complete with ...

$ 2000


Global Markets Direct's, ‘House Dust Mite Allergy Pipeline Review, H2 2014', provides an overview of the House Dust Mite Allergy's therapeutic pipeline.This report provides comprehensive information on the therapeutic developmen...

$ 2000


Global Markets Direct's, ‘Pulmonary Tuberculosis Pipeline Review, H2 2014', provides an overview of the Pulmonary Tuberculosis's therapeutic pipeline.This report provides comprehensive information on the therapeutic development ...

$ 2000


Global Markets Direct's, ‘Post Menopausal Osteoporosis Pipeline Review, H2 2014', provides an overview of the Post Menopausal Osteoporosis's therapeutic pipeline.This report provides comprehensive information on the therapeutic ...

$ 2000


Global Markets Direct's, ‘Hairy Cell Leukemia Pipeline Review, H2 2014', provides an overview of the Hairy Cell Leukemia's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Ha...

$ 2000


Global Markets Direct's, ‘Refractory Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H2 2014', provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL)'s therapeutic pipeline.This report provides comprehensi...

$ 2000


Global Markets Direct's, ‘Cerebral Palsy Pipeline Review, H2 2014', provides an overview of the Cerebral Palsy's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cerebral Pal...

$ 2000


Global Markets Direct's, ‘Relapsing Multiple Sclerosis (RMS) Pipeline Review, H2 2014', provides an overview of the Relapsing Multiple Sclerosis (RMS)'s therapeutic pipeline.This report provides comprehensive information on the ...

$ 2000


Global Markets Direct's, ‘Epidermolysis Bullosa Pipeline Review, H2 2014', provides an overview of the Epidermolysis Bullosa's therapeutic pipeline.This report provides comprehensive information on the therapeutic development fo...

$ 2000


Global Markets Direct's, ‘Genital Herpes Pipeline Review, H2 2014', provides an overview of the Genital Herpes's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Genital Herp...

$ 2000


Global Markets Direct's, ‘Etubics Corporation Product Pipeline Review 2014', provides an overview of the Etubics Corporation's pharmaceutical research and development focus.This report provides comprehensive information on the c...

$ 1500


Global Markets Direct's, ‘Sutro Biopharma, Inc. Product Pipeline Review 2014', provides an overview of the Sutro Biopharma, Inc.'s pharmaceutical research and development focus.This report provides comprehensive information on t...

$ 1500

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

> Live Chat
Live Chat by Comm100